Para Wegovy (indicacin de prdida de peso), los criterios de elegibilidad incluyen: IMC 30 kg/m (obesidad) sin otras condiciones, o IMC 27 kg/m (sobrepeso) con al menos una comorbilidad relacionada con el peso (hipertensin, dislipidemia, diabetes tipo 2, enfermedad cardiovascular, apnea del sueo) Edad de 18 aos o mayor (tambin aprobado para adolescentes de 12 aos o ms con IMC percentil 95 para su edad y sexo) Compromiso con cambios en el estilo de vida, incluyendo dieta reducida en caloras y aumento de actividad fsica El mdico debe documentar intentos previos de prdida de peso mediante modificaciones del estilo de vida y evaluar si existen contraindicaciones
Neurology 2001, 56: 1405-1409
Health care professionals and consumers should report adverse events or side effects related to the use of this product to FDAs MedWatch Safety Information and Adverse Event Reporting Program: Complete and submit the report online at MedWatch Online Voluntary Reporting Form or Download and complete the form, then submit it via fax at 1-800-FDA-0178
Its fantastic knowing youve been part of creating something with such a profound impact on human health. The journey so far, born from a reluctant chemists leap into the unknown, has already changed millions of lives and the story continues
Pe langa pierderea de grasime, alte beneficii ale L-carnitinei includ rezistenta crescuta si recuperarea musculara sporita
The case joins a growing wave of litigation against major food manufacturers including Coca-Cola, Kraft Heinz, PepsiCo, Nestl, and Mondelez